Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial

BACKGROUND: Cardiovascular disease in particular acute coronary syndrome (ACS) is remained one of the most cause of morbidity and mortality, annually. Considering inflammatory pathway of atherosclerosis, colchicine as an anti-inflammatory drug is introduced to be effective in pathogenesis, prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Akrami, Mehdi, Izadpanah, Peyman, Bazrafshan, Mehdi, Hatamipour, Unes, Nouraein, Navid, Drissi, Hamed Bazrafshan, Manafi, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650300/
https://www.ncbi.nlm.nih.gov/pubmed/34876021
http://dx.doi.org/10.1186/s12872-021-02393-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650300/
https://www.ncbi.nlm.nih.gov/pubmed/34876021
http://dx.doi.org/10.1186/s12872-021-02393-9

Ejemplares similares